{"id":"https://openalex.org/W2013754529","doi":"https://doi.org/10.1097/00001813-199811000-00009","title":"Cost-utility model comparing docetaxel and paclitaxel in advanced breast cancer patients","display_name":"Cost-utility model comparing docetaxel and paclitaxel in advanced breast cancer patients","publication_year":1998,"publication_date":"1998-11-01","ids":{"openalex":"https://openalex.org/W2013754529","doi":"https://doi.org/10.1097/00001813-199811000-00009","mag":"2013754529","pmid":"https://pubmed.ncbi.nlm.nih.gov/9890701"},"language":"en","primary_location":{"id":"doi:10.1097/00001813-199811000-00009","doi":"https://doi.org/10.1097/00001813-199811000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-199811000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071109746","display_name":"Ruth E. Brown","orcid":"https://orcid.org/0000-0001-8897-3138","observed_orcids":["https://orcid.org/0000-0001-8897-3138"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruth E Brown","raw_affiliation_strings":["MEDTAP International, Inc, Bethesda, MD 20814, USA","654\u20139729"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MEDTAP International, Inc, Bethesda, MD 20814, USA","institution_ids":[]},{"raw_affiliation_string":"654\u20139729","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110358211","display_name":"John Hutton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Hutton","raw_affiliation_strings":["MEDTAP International, Inc, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA. Tel: (+1) 301 654\u20139729","654\u20139729"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MEDTAP International, Inc, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA. Tel: (+1) 301 654\u20139729","institution_ids":[]},{"raw_affiliation_string":"654\u20139729","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.7177,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.96174906,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"9","issue":"10","first_page":"899","last_page":"908"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9959999918937683},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cost-utility-analysis","display_name":"cost-utility analysis","score":0.8880000114440918},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9020000100135803},{"id":"https://openalex.org/keywords/chemotherapy-costs","display_name":"chemotherapy costs","score":0.37400001287460327},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.7269999980926514},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.7509999871253967},{"id":"https://openalex.org/keywords/treatment-response-rate","display_name":"treatment response rate","score":0.5170000195503235},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.33500000834465027}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9792316555976868},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.83497154712677},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7402161955833435},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6930135488510132},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6223983764648438},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5372670888900757},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5082144737243652},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5017383098602295},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.44341376423835754},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4055749773979187}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003365","descriptor_name":"Costs and Cost Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019366","descriptor_name":"Western World","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00001813-199811000-00009","doi":"https://doi.org/10.1097/00001813-199811000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-199811000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:9890701","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9890701","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1968578586","https://openalex.org/W2012898987","https://openalex.org/W2416572460","https://openalex.org/W2058294694","https://openalex.org/W2337202066","https://openalex.org/W1994561005","https://openalex.org/W2062870366","https://openalex.org/W2042826255","https://openalex.org/W2012434503","https://openalex.org/W4413702117"],"abstract_inverted_index":{"Relevant":[0],"data":[1,63,99,166],"from":[2,82,105],"direct":[3],"comparisons":[4],"in":[5,18,36,46,52,153,174],"clinical":[6,61],"trials":[7],"are":[8],"not":[9],"available":[10,60],"for":[11,42,68,72],"economic":[12],"evaluations":[13],"of":[14,21,66,121,160],"docetaxel":[15,43,69,119,144],"and":[16,70,79,95,113,147,151,167],"paclitaxel":[17,45,136],"the":[19,33,53,58],"management":[20,120],"metastatic":[22,48],"breast":[23,49,123],"cancer.":[24],"A":[25],"modified":[26],"Markov":[27],"model":[28,56,163],"is":[29,125,145],"used":[30],"to":[31,77],"estimate":[32],"incremental":[34],"cost":[35,139],"US$":[37],"per":[38,128,140],"quality-adjusted":[39],"life-year":[40],"(QALY)":[41],"versus":[44],"managing":[47],"cancer":[50,124],"patients":[51],"US.":[54],"The":[55,110,138],"incorporates":[57],"latest":[59],"trial":[62],"(response":[64],"rates":[65],"47.8%":[67],"25%":[71],"paclitaxel,":[73],"chemotherapy-specific":[74],"toxicities,":[75],"time":[76],"progression,":[78],"1-year":[80],"survival)":[81],"studies":[83],"against":[84],"other":[85,171],"comparators.":[86],"Medical":[87],"care":[88],"resources":[89],"were":[90,103],"estimated":[91],"by":[92,143],"US":[93,98,107],"oncologists":[94],"costed":[96],"using":[97,164],"sources.":[100],"Utility":[101],"scores":[102],"obtained":[104],"29":[106],"oncology":[108],"nurses.":[109],"base":[111],"case":[112],"subsequent":[114],"sensitivity":[115,154],"analyses":[116],"show":[117],"that":[118],"advanced":[122],"more":[126],"costly":[127],"patient":[129,176],"but":[130],"yields":[131],"higher":[132],"health":[133],"benefits":[134],"than":[135],"therapy.":[137],"QALY":[141],"gained":[142],"$8615,":[146],"ranges":[148],"between":[149],"$3943":[150],"$9416":[152],"analyses.":[155],"These":[156],"results":[157,173],"confirm":[158],"those":[159],"an":[161],"earlier":[162],"preliminary":[165],"compare":[168],"favorably":[169],"with":[170],"cost-utility":[172],"this":[175],"group.":[177]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}